Rein Therapeutics logo
Rein Therapeutics
RNTX | NASDAQ
Chart Builder DCF Calculator
$0.40
-$0.15 (-27.55%)
At close: Nov 16, 2026, 4:00 PM ET
$0.38
-$0.02 (-5.35%)
After-hours: Nov 16, 2026, 7:30 PM ET

Rein Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
1K – – – – –
-1K – – – – –
-21.93M -65.11M -16.28K -27.65K -26.61K -20.5K
– 400K 600 – – –
-50.58M -64.31M -15.73K -27.33K -26.16K -21.16K
-49.87M -62.88M -15.73K -27.33K -26.16K -21.16K
10.9M 13.86M 11.36K 9.68K 9.6K 9.33K
11.03M 14.25M 3.99K 17.97K 17.01K 11.17K
-1K 37M 928 – – –
21.93M 65.11M 16.28K 27.65K 26.61K 20.5K
– – – – – –
– – – – – –
21.93M 65.11M 16.28K 27.65K 26.61K 20.5K
-712K -1.54M – – – –
25.44M 17.94M 4.6M 4.54M 4.44M 17.43M
25.44M 17.94M 4.6M 4.54M 4.44M 17.43M
-1.96 -3.51 -3.42 -6.02 -5.89 0
-1.96 -3.51 -3.42 -6.02 -5.89 0
-50.58M -28.05M 103.65K 141.67K 94.84K 142.5K
-50.58M -28.11M -15.35K -27.33K -26.16K -20.5K
1K 63K 119K 169K 121K 163K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.